Testing ovarian reserve to predict age at menopause

Maturitas

Volumn 63, Issue 4, 2009, Pages 280-291

  Lambalk, C B ^a   van Disseldorp, J ^b   de Koning, C H ^c   Broekmans, F J ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Anti M llerian hormone; Antral follicle count; Follicle stimulating hormone; Menopause; Ovarian reserve tests; Reproductive genetics

Indexed keywords

ACTIVIN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PROGESTERONE;

AGING; EARLY MENOPAUSE; ESTRADIOL BLOOD LEVEL; FAMILY HISTORY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONAL REGULATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MENOPAUSE; OVARIAN RESERVE; OVARY FUNCTION; PREDICTION; PROGESTERONE BLOOD LEVEL; REVIEW;

AGE FACTORS; FEMALE; FERTILITY; HUMANS; MENOPAUSE; OVARY;

EID: 68149178652     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.06.007     Document Type: Review

References (188)

1. Treloar A.E. Menstrual cyclicity and the pre-menopause. Maturitas 3 (1981) 249-264
2. Coulam C.B., Adamson S.C., and Annegers J.F. Incidence of premature ovarian failure. Obstet Gynecol 67 (1986) 604-606
3. van der Schouw Y.T., van der Graaf Y., Steyerberg E.W., Eijkemans J.C., and Banga J.D. Age at menopause as a risk factor for cardiovascular mortality. Lancet 347 (1996) 714-718
4. Der Voort D.J., Der Weijer P.H., and Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int 14 (2003) 525-530
5. van Wayenburg C.A., van der Schouw Y.T., van Noord P.A., and Peeters P.H. Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort. Epidemiology 11 (2000) 304-308
6. Mondul A.M., Rodriguez C., Jacobs E.J., and Calle E.E. Age at natural menopause and cause-specific mortality. Am J Epidemiol 162 (2005) 1089-1097
7. te Velde E.R., and Pearson P.L. The variability of female reproductive ageing. Hum Reprod Update 8 (2002) 141-154
8. Baker T.G. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 158 (1963) 417-433
9. Block E. Quantitative morphological investigations of the follicular system in women; variations at different ages. Acta Anat (Basel) 14 (1952) 108-123
10. Block E. A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anat (Basel) 17 (1953) 201-206
11. Faddy M.J., Gosden R.G., Gougeon A., Richardson S.J., and Nelson J.F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 7 (1992) 1342-1346
12. Gougeon A., and Chainy G.B. Morphometric studies of small follicles in ovaries of women at different ages. J Reprod Fertil 81 (1987) 433-442
13. Hansen K.R., Knowlton N.S., Thyer A.C., Charleston J.S., Soules M.R., and Klein N.A. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod 23 (2008) 699-708
14. Leidy L.E., Godfrey L.R., and Sutherland M.R. Is follicular atresia biphasic?. Fertil Steril 70 (1998) 851-859
15. Richardson S.J., Senikas V., and Nelson J.F. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 65 (1987) 1231-1237
16. Faddy M.J., and Gosden R.G. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 11 (1996) 1484-1486
17. Faddy M.J. Follicle dynamics during ovarian ageing. Mol Cell Endocrinol 163 (2000) 43-48
18. de Bruin J.P., Dorland M., Spek E.R., et al. Age-related changes in the ultrastructure of the resting follicle pool in human ovaries. Biol Reprod 70 (2004) 419-424
19. Klinkert ER. Clinical significance and management of poor response in IVF. Academic Thesis, Utrecht; 2005.
20. Broekmans F.J., Faddy M.J., Scheffer G., and te Velde E.R. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause 11 (2004) 607-614
21. den Tonkelaar I., te Velde E.R., and Looman C.W. Menstrual cycle length preceding menopause in relation to age at menopause. Maturitas 29 (1998) 115-123
22. Bouchard G. Population studies and genetic epidemiology in northeast Quebec. Can Stud Popul 16 (1989) 61-86
23. Eijkemans M.J., Habbema J.D.F., and te Velde E.R. Age at last childbirth and fertility at young age. In: Eijkemans M.J. (Ed). Fertility in populations and in patients (2005), Academic Thesis, Rotterdam 23-34
24. Lisabeth L., Harlow S., and Qaqish B. A new statistical approach demonstrated menstrual patterns during the menopausal transition did not vary by age at menopause. J Clin Epidemiol 57 (2004) 484-496
25. de Boer E.J., den Tonkelaar I., te Velde E.R., Burger C.W., and van Leeuwen F.E. Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 18 (2003) 1544-1552
26. Lawson R., El Toukhy T., Kassab A., et al. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod 18 (2003) 527-533
27. Nikolaou D., Lavery S., Turner C., Margara R., and Trew G. Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?. Hum Reprod 17 (2002) 1106-1111
28. van Noord-Zaadstra B.M., Looman C.W., Alsbach H., Habbema J.D., te Velde E.R., and Karbaat J. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ 302 (1991) 1361-1365
29. Treloar A.E., Boynton R.E., Behn B.G., and Brown B.W. Variation of the human menstrual cycle through reproductive life. Int J Fertil 12 (1967) 77-126
30. Abma J.C., Chandra A., Mosher W.D., Peterson L.S., and Piccinino L.J. Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital Health Stat 23 (1997) 1-114
31. Evers J.L. Female subfertility. Lancet 360 (2002) 151-159
32. Centers for Disease Control and Prevention. Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports; 2005. http://www.cdc.gov/ART/ART2005-508PDF/2005ART508.pdf.
33. FIVNAT. Pregnancies and births resulting from in vitro fertilization: French national registry analysis of data 1986 to 1990. Fertil Steril 64 (1995) 746-756
34. Templeton A., Morris J.K., and Parslow W. Factors that affect outcome of in-vitro fertilisation treatment. Lancet 348 (1996) 1402-1406
35. Leridon H. Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod 19 (2004) 1548-1553
36. Grant J, Hoorens S, Gallo F, Cave J. Should ART be part of a population policy mix? A preliminary assessment of the demographic and economic impact of assisted reproductive technologies. www.rand.org. 1-6-2006. RAND cooperation.
37. Habbema J.D., Eijkemans M.J., Nargund G., Beets G., Leridon H., and te Velde E.R. The effect of in vitro fertilization on birth rates in western countries. Hum Reprod (2009)
38. O'Connor K.A., Holman D.J., and Wood J.W. Declining fecundity and ovarian ageing in natural fertility populations. Maturitas 30 (1998) 127-136
39. Wood J.W. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol 11 (1989) 61-109
40. Spira A. The decline of fecundity with age. Maturitas Suppl. 1 (1988) 15-22
41. Bouchard G. Family reproduction in new rural areas: outline of a North American model. Can Hist Rev 75 (1994) 475-510
42. Soules M.R., Sherman S., Parrott E., et al. Stages of Reproductive Aging Workshop (STRAW). J Womens Health Gend Based Med 10 (2001) 843-848
43. Weinstein M., Gorrindo T., Riley A., et al. Timing of menopause and patterns of menstrual bleeding. Am J Epidemiol 158 (2003) 782-791
44. Vollman R.F. The menstrual cycle. Major Probl Obstet Gynecol 7 (1977) 1-193
45. Bengtsson C., Lindquist O., and Redvall L. Menstrual status and menopausal age of middle-aged Swedish women. A population study of women in Goteborg 1968-69 and 1974-75. Acta Obstet Gynecol Scand 60 (1981) 269-275
46. Hagstad A., Johansson S., Wilhelmsson C., and Janson P.O. Gynaecology of middle-aged women-menstrual and reproductive histories. Maturitas 7 (1985) 99-113
47. Luoto R., Kaprio J., and Uutela A. Age at natural menopause and sociodemographic status in Finland. Am J Epidemiol 139 (1994) 64-76
48. Magursky V., Mesko M., and Sokolik L. Age at the menopause and onset of the climacteric in women of Martin District, Czechoslovkia. Statistical survey and some biological and social correlations. Int J Fertil 20 (1975) 17-23
49. van Noord P.A., Dubas J.S., Dorland M., Boersma H., and te Velde E. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril 68 (1997) 95-102
50. Riboli E., Hunt K.J., Slimani N., et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 5 (2002) 1113-1124
51. de Vries E., den Tonkelaar I., van Noord P.A., van der Schouw Y.T., te Velde E.R., and Peeters P.H. Oral contraceptive use in relation to age at menopause in the DOM cohort. Hum Reprod 16 (2001) 1657-1662
52. Lawlor D.A., Ebrahim S., and Smith G.D. The association of socio-economic position across the life course and age at menopause: the British Women's Heart and Health Study. BJOG 110 (2003) 1078-1087
53. van Asselt K.M., Kok H.S., Peeters P.H., et al. Factor V Leiden mutation accelerates the onset of natural menopause. Menopause 10 (2003) 477-481
54. Broekmans F.J., Kwee J., Hendriks D.J., Mol B.W., and Lambalk C.B. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12 (2006) 685-718
55. Broekmans F.J., Knauff E.A., te Velde E.R., Macklon N.S., and Fauser B.C. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab 18 (2007) 58-65
56. Broekmans F.J., Visser J.A., Laven J.S., Broer S.L., Themmen A.P., and Fauser B.C. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab 19 (2008) 340-347
57. van Disseldorp J., Faddy M.J., Themmen A.P., et al. Relationship of serum antimullerian hormone concentration to age at menopause. J Clin Endocrinol Metab 93 (2008) 2129-2134
58. Wallace W.H., and Kelsey T.W. Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Hum Reprod 19 (2004) 1612-1617
59. Lass A., Silye R., Abrams D.C., et al. Follicular density in ovarian biopsy of infertile women: a novel method to assess ovarian reserve. Hum Reprod 12 (1997) 1028-1031
60. Lass A. Assessment of ovarian reserve-is there a role for ovarian biopsy?. Hum Reprod 16 (2001) 1055-1057
61. Lambalk C.B., de Koning C.H., Flett A., van Kasteren Y., Gosden R., and Homburg R. Assessment of ovarian reserve. Ovarian biopsy is not a valid method for the prediction of ovarian reserve. Hum Reprod 19 (2004) 1055-1059
62. Poirot C., Vacher-Lavenu M.C., Helardot P., Guibert J., Brugieres L., and Jouannet P. Human ovarian tissue cryopreservation: indications and feasibility. Hum Reprod 17 (2002) 1447-1452
63. Qu J., Godin P.A., Nisolle M., and Donnez J. Distribution and epidermal growth factor receptor expression of primordial follicles in human ovarian tissue before and after cryopreservation. Hum Reprod 15 (2000) 302-310
64. Schmidt K.L., Ernst E., Byskov A.G., Nyboe A.A., and Yding A.C. Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation. Hum Reprod 18 (2003) 2654-2659
65. Klein N.A., Houmard B.S., Hansen K.R., et al. Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab 89 (2004) 2977-2981
66. Sherman B.M., West J.H., and Korenman S.G. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42 (1976) 629-636
67. Lee S.J., Lenton E.A., Sexton L., and Cooke I.D. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 3 (1988) 851-855
68. Lenton E.A., King H., Thomas E.J., et al. The endocrine environment of the human oocyte. J Reprod Fertil 82 March (1988) 827-841
69. MacNaughton J., Banah M., McCloud P., Hee J., and Burger H. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age. Clin Endocrinol Oxf 36 (1992) 339-345
70. Reyes F.I., Winter J.S., and Faiman C. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 129 (1977) 557-564
71. van Rooij I.A., Tonkelaar I., Broekmans F.J., et al. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11 (2004) 601-606
72. van Rooij I.A., Broekmans F.J., Scheffer G.J., et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 83 (2005) 979-987
73. van Montfrans J.M., Hoek A., van Hooff M.H., de Koning C.H., Tonch N., and Lambalk C.B. Predictive value of basal follicle-stimulating hormone concentrations in a general subfertility population. Fertil Steril 74 (2000) 97-103
74. Sowers M.R., Eyvazzadeh A.D., McConnell D., et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 93 (2008) 3478-3483
75. Vale W., Rivier C., Hsueh A., et al. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 44 (1988) 1-34
76. Weiss J., Crowley W.F.J., Halvorson L.M., and Jameson J.L. Perifusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion. Endocrinology 132 (1993) 2307-2311
77. Roberts V.J., Barth S., el Roeiy A., and Yen S.S. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 77 (1993) 1402-1410
78. Groome N.P., Illingworth P.J., O'Brien M., et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81 (1996) 1401-1405
79. Danforth D.R., Arbogast L.K., Mroueh J., et al. Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 70 (1998) 119-123
80. Dudley E.C., Hopper J.L., Taffe J., Guthrie J.R., Burger H.G., and Dennerstein L. Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric 1 (1998) 18-25
81. Santoro N., Adel T., and Skurnick J.H. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 71 (1999) 658-662
82. Welt C.K., McNicholl D.J., Taylor A.E., and Hall J.E. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 84 (1999) 105-111
83. Reame N.E., Wyman T.L., Phillips D.J., de Kretser D.M., and Padmanabhan V. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J Clin Endocrinol Metab 83 (1998) 3302-3307
84. Klein N.A., Illingworth P.J., Groome N.P., McNeilly A.S., Battaglia D.E., and Soules M.R. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81 (1996) 2742-2745
85. Muttukrishna S., Child T., Lockwood G.M., Groome N.P., Barlow D.H., and Ledger W.L. Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women. Hum Reprod 15 (2000) 549-556
86. Santoro N., Isaac B., Neal-Perry G., et al. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab 88 (2003) 5502-5509
87. Seifer D.B., Lambert Messerlian G., Hogan J.W., Gardiner A.C., Blazar A.S., and Berk C.A. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 67 (1997) 110-114
88. Gougeon A. Caracteres qualitatifs et quantitatifs de la population folliculaire dans l'ovaire humaine adulte. Contracept. Fertil. Sex. 12 3 (1984) 527-535
89. Fanchin R., Schonauer L.M., Righini C., Guibourdenche J., Frydman R., and Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18 (2003) 323-327
90. Ficicioglu C., Kutlu T., Baglam E., and Bakacak Z. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 85 (2006) 592-596
91. La Marca A., Stabile G., Artenisio A.C., and Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 21 (2006) 3103-3107
92. Seifer D.B., MacLaughlin D.T., Christian B.P., Feng B., and Shelden R.M. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77 (2002) 468-471
93. Visser J.A., de Jong F.H., Laven J.S., and Themmen A.P. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 131 (2006) 1-9
94. de Vet A., Laven J.S., de Jong F.H., Themmen A.P., and Fauser B.C. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77 (2002) 357-362
95. Cook C.L., Siow Y., Taylor S., and Fallat M.E. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 73 (2000) 859-861
96. Hehenkamp W.J., Looman C.W., Themmen A.P., de Jong F.H., te Velde E.R., and Broekmans F.J. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 91 (2006) 4057-4063
97. Fanchin R., Taieb J., Lozano D.H., Ducot B., Frydman R., and Bouyer J. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 20 (2005) 923-927
98. Lenton E.A., de Kretser D.M., Woodward A.J., and Robertson D.M. Inhibin concentrations throughout the menstrual cycles of normal, infertile, and older women compared with those during spontaneous conception cycles. J Clin Endocrinol Metab 73 (1991) 1180-1190
99. Klein N.A., Battaglia D.E., Fujimoto V.Y., Davis G.S., Bremner W.J., and Soules M.R. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 81 (1996) 1038-1045
100. Klein N.A., Battaglia D.E., Woodruff T.K., et al. Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. J Clin Endocrinol Metab 85 (2000) 4520-4525
101. Klein N.A., Harper A.J., Houmard B.S., Sluss P.M., and Soules M.R. Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development?. J Clin Endocrinol Metab 87 (2002) 5746-5750
102. Reame N.E., Kelche R.P., Beitins I.Z., Yu M.Y., Zawacki C.M., and Padmanabhan V. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women. J Clin Endocrinol Metab 81 (1996) 1512-1518
103. Kim Y.K., Wasser S.K., Fujimoto V.Y., Klein N.A., Moore D.E., and Soules M.R. Utility of follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol and FSH:LH ratio in predicting reproductive age in normal women. Hum Reprod 12 (1997) 1152-1155
104. Musey V.C., Collins D.C., Musey P.I., Martino Saltzman D., and Preedy J.R. Age-related changes in the female hormonal environment during reproductive life. Am J Obstet Gynecol 157 (1987) 312-317
105. Santoro N., Brown J.R., Adel T., and Skurnick J.H. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 81 (1996) 1495-1501
106. de Koning C.H., Popp-Snijders C., Schoemaker J., and Lambalk C.B. Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH. Hum Reprod 15 (2000) 1452-1456
107. de Koning C.H., McDonnell J., Themmen A.P., de Jong F.H., Homburg R., and Lambalk C.B. The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls. Hum Reprod 23 (2008) 1416-1423
108. Fitzgerald C.T., Seif M.W., Killick S.R., and Bennett D.A. Age related changes in the female reproductive cycle. Br J Obstet Gynaecol 101 (1994) 229-233
109. Klein N.A., Battaglia D.E., Miller P.B., Branigan E.F., Giudice L.C., and Soules M.R. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. J Clin Endocrinol Metab 81 (1996) 1946-1951
110. Lenton E.A., Landgren B.M., Sexton L., and Harper R. Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol 91 (1984) 681-684
111. van Zonneveld P., Scheffer G.J., Broekmans F.J., et al. Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women. Hum Reprod 18 (2003) 495-501
112. Ahmed Ebbiary N.A., Lenton E.A., and Cooke I.D. Hypothalamic-pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women. Clin Endocrinol Oxf 41 (1994) 199-206
113. Messinis I.E. Ovarian feedback, mechanism of action and possible clinical implications. Hum Reprod Update 12 (2006) 557-571
114. Bulmer M.G. The biology of twinning in man (1970), Clarendon, Oxford
115. Beemsterboer S.N., Homburg R., Gorter N.A., Schats R., Hompes P.G., and Lambalk C.B. The paradox of declining fertility but increasing twinning rates with advancing maternal age. Hum Reprod 21 (2006) 1531-1532
116. Lambalk C.B., de Koning C.H., van der Meer M., and Schoemaker J. Role of age and ovary status in ovulation induction. Proceedings of the 2nd world conference on ovulation induction. Partenon Publishing Group (1998) 29-36
117. Lambalk C. Menstrual cycle abnormalities and ovarian failure. In: Filicori M. (Ed). Reproductive medicine: current concepts and new perspectives (1998), Scientific Projects International, Bologna, Italy 1-10
118. Van Voorhis B.J., Santoro N., Harlow S., Crawford S.L., and Randolph J. The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol 112 (2008) 101-108
119. Skurnick J.H., Weiss G., Goldsmith L.T., Santoro N., and Crawford S. Longitudinal changes in hypothalamic and ovarian function in perimenopausal women with anovulatory cycles: relationship with vasomotor symptoms. Fertil Steril 91 (2009) 1127-1134
120. Santoro N., Brockwell S., Johnston J., et al. Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause 14 (2007) 415-424
121. Merce L.T., Gomez B., Engels V., Bau S., and Bajo J.M. Intraobserver and interobserver reproducibility of ovarian volume, antral follicle count, and vascularity indices obtained with transvaginal 3-dimensional ultrasonography, power Doppler angiography, and the virtual organ computer-aided analysis imaging program. J Ultrasound Med 24 (2005) 1279-1287
122. Brett S., Bee N., Wallace W.H., Rajkhowa M., and Kelsey T.W. Individual ovarian volumes obtained from 2-dimensional and 3-dimensional ultrasound lack precision. Reprod Biomed Online 18 (2009) 348-351
123. Jayaprakasan K., Campbell B., Hopkisson J., Clewes J., Johnson I., and Raine-Fenning N. Establishing the intercycle variability of three-dimensional ultrasonographic predictors of ovarian reserve. Fertil Steril 90 (2008) 2126-2132
124. Engmann L., Sladkevicius P., Agrawal R., Bekir J., Campbell S., and Tan S.L. The pattern of changes in ovarian stromal and uterine artery blood flow velocities during in vitro fertilization treatment and its relationship with outcome of the cycle. Ultrasound Obstet Gynecol 13 (1999) 26-33
125. Adali E., Kolusari A., Adali F., Yildizhan R., Kurdoglu M., and Sahin H.G. Doppler analysis of uterine perfusion and ovarian stromal blood flow in polycystic ovary syndrome. Int J Gynaecol Obstet 105 (2009) 154-157
126. Agrawal R., Conway G., Sladkevicius P., et al. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril 70 (1998) 651-658
127. Lam P.M., Johnson I.R., and Raine-Fenning N.J. Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Reprod 22 (2007) 3116-3123
128. Mala Y.M., Ghosh S.B., and Tripathi R. Three-dimensional power Doppler imaging in the diagnosis of polycystic ovary syndrome. Int J Gynaecol Obstet 105 (2009) 36-38
129. Kupesic S., Kurjak A., Bjelos D., and Vujisic S. Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age. Fertil Steril 79 (2003) 190-197
130. Engmann L., Sladkevicius P., Agrawal R., Bekir J.S., Campbell S., and Tan S.L. Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment. Fertil Steril 71 (1999) 22-29
131. Popovic-Todorovic B., Loft A., Lindhard A., Bangsboll S., Andersson A.M., and Andersen A.N. A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod 18 (2003) 781-787
132. Kupesic S., and Kurjak A. Predictors of IVF outcome by three-dimensional ultrasound. Hum Reprod 17 (2002) 950-955
133. Younis J.S., Haddad S., Matilsky M., Radin O., and Ben-Ami M. Undetectable basal ovarian stromal blood flow in infertile women is related to low ovarian reserve. Gynecol Endocrinol 23 (2007) 284-289
134. Zaidi J., Barber J., Kyei Mensah A., Bekir J., Campbell S., and Tan S.L. Relationship of ovarian stromal blood flow at the baseline ultrasound scan to subsequent follicular response in an in vitro fertilization program. Obstet Gynecol 88 (1996) 779-784
135. Lass A., Skull J., McVeigh E., Margara R., and Winston R.M. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 12 (1997) 294-297
136. Pavlik E.J., DePriest P.D., Gallion H.H., et al. Ovarian volume related to age. Gynecol Oncol 77 (2000) 410-412
137. Bancsi L.F., Broekmans F.J., Eijkemans M.J., de Jong F.H., Habbema J.D., and te Velde E.R. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 77 (2002) 328-336
138. Hendriks D.J., Kwee J., Mol B.W., te Velde E.R., and Broekmans F.J. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril 87 (2007) 764-775
139. Jayaprakasan K., Hilwah N., Kendall N.R., et al. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment?. Hum Reprod 22 (2007) 1932-1941
140. Jayaprakasan K., Campbell B., Hopkisson J., Johnson I., and Raine-Fenning N. A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril (2008)
141. Kwee J., Elting M.E., Schats R., McDonnell J., and Lambalk C.B. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization. Reprod Biol Endocrinol 5 (2007) 9
142. Kwee J., Schats R., McDonnell J., Themmen A., de Jong F., and Lambalk C. Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril 90 (2008) 737-743
143. Flaws J.A., Langenberg P., Babus J.K., Hirshfield A.N., and Sharara F.I. Ovarian volume and antral follicle counts as indicators of menopausal status. Menopause 8 (2001) 175-180
144. Giacobbe M., Mendes Pinto-Neto A., Simoes Costa-Paiva L.H., and Martinez E.Z. The usefulness of ovarian volume, antral follicle count and age as predictors of menopausal status. Climacteric 7 (2004) 255-260
145. Scheffer G.J., Broekmans F.J., Dorland M., Habbema J.D., Looman C.W., and te Velde E.R. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 72 (1999) 845-851
146. Meldrum D.R., Chetkowski R.J., Steingold K.A., and Randle D. Transvaginal ultrasound scanning of ovarian follicles. Fertil Steril 42 (1984) 803-805
147. Pache T.D., Wladimiroff J.W., de Jong F.H., Hop W.C., and Fauser B.C.J.M. Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril 54 (1990) 638-642
148. Cramer D.W., Xu H., and Harlow B.L. Family history as a predictor of early menopause. Fertil Steril 64 (1995) 740-745
149. de Bruin J.P., Bovenhuis H., van Noord P.A., et al. The role of genetic factors in age at natural menopause. Hum Reprod 16 (2001) 2014-2018
150. Murabito J.M., Yang Q., Fox C., Wilson P.W., and Cupples L.A. Heritability of age at natural menopause in the Framingham Heart Study. J Clin Endocrinol Metab 90 (2005) 3427-3430 42480
151. Torgerson D.J., Thomas R.E., and Reid D.M. Mothers and daughters menopausal ages: is there a link?. Eur J Obstet Gynecol Reprod Biol 74 (1997) 63-66 42481
152. van Asselt K.M., Kok H.S., Pearson P.L., et al. Heritability of menopausal age in mothers and daughters. Fertil Steril 82 (2004) 1348-1351
153. Wicks J., Treloar S.A., and Martin N.G. Using identity-by-descent information in affected sib pairs to increase the efficiency of genetic association studies. Twin Res 7 (2004) 211-216
154. Simpson J.L., and Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet 89 (1999) 186-200
155. Welt C.K., Smith P.C., and Taylor A.E. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 89 (2004) 4569-4574
156. Wittenberger M.D., Hagerman R.J., Sherman S.L., et al. The FMR1 premutation and reproduction. Fertil Steril 87 (2007) 456-465
157. Skillern A., and Rajkovic A. Recent developments in identifying genetic determinants of premature ovarian failure. Sex Dev 2 (2008) 228-243
158. Kok H.S., van Asselt K.M., van der Schouw Y.T., Peeters P.H., and Wijmenga C. Genetic studies to identify genes underlying menopausal age. Hum Reprod Update 11 (2005) 483-493
159. Kok H.S., van Asselt K.M., van der Schouw Y.T., et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 47 (2006) 1976-1983
160. Koochmeshgi J., Hosseini-Mazinani S.M., Morteza S.S., Hosein-Pur-Nobari N., and Teimoori-Toolabi L. Apolipoprotein E genotype and age at menopause. Ann N Y Acad Sci 1019 (2004) 564-567
161. Pripp U., Eriksson-Berg M., Orth-Gomer K., Schenck-Gustafsson K., and Landgren B.M. Does body mass index, smoking, lipoprotein levels, surgically induced menopause, hormone replacement therapy, years since menopause, or age affect hemostasis in postmenopausal women?. Gend Med 2 (2005) 88-95
162. Gaulden M.E. Maternal age effect: the enigma of Down syndrome and other trisomic conditions. Mutat Res 296 (1992) 69-88
163. Tarin J.J. Aetiology of age-associated aneuploidy: a mechanism based on the 'free radical theory of ageing'. Hum Reprod 10 (1995) 1563-1565
164. Tempfer C.B., Riener E.K., Keck C., et al. Polymorphisms associated with thrombophilia and vascular homeostasis and the timing of menarche and menopause in 728 white women. Menopause 12 (2005) 325-330
165. Van Blerkom J., Antczak M., and Schrader R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 12 (1997) 1047-1055
166. Weel A.E., Uitterlinden A.G., Westendorp I.C., et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 84 (1999) 3146-3150
167. Gorai I., Tanaka K., Inada M., et al. Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. J Clin Endocrinol Metab 88 (2003) 799-803
168. Kok H.S., Onland-Moret N.C., van Asselt K.M., et al. No association of estrogen receptor alpha and cytochrome P450c17alpha polymorphisms with age at menopause in a Dutch cohort. Hum Reprod 20 (2005) 536-542
169. Kevenaar M.E., Themmen A.P., Rivadeneira F., et al. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod 22 (2007) 2382-2388
170. van Asselt K.M., Kok H.S., Putter H., et al. Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age. Am J Hum Genet 74 (2004) 444-453
171. Hsu S.Y., and Hsueh A.J. Tissue-specific Bcl-2 protein partners in apoptosis: An ovarian paradigm. Physiol Rev 80 (2000) 593-614
172. Petros A.M., Olejniczak E.T., and Fesik S.W. Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644 (2004) 83-94
173. Atwood L.D., and Heard-Costa N.L. Limits of fine-mapping a quantitative trait. Genet Epidemiol 24 (2003) 99-106
174. Hehenkamp W.J., Volkers N.A., Broekmans F.J., et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod 22 (2007) 1996-2005
175. Larsen E.C., Muller J., Schmiegelow K., Rechnitzer C., and Andersen A.N. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88 (2003) 5307-5314
176. Lass A., Ellenbogen A., Croucher C., et al. Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program. Fertil Steril 70 (1998) 1035-1038
177. Tulandi T., Sammour A., Valenti D., Child T.J., Seti L., and Tan S.L. Ovarian reserve after uterine artery embolization for leiomyomata. Fertil Steril 78 (2002) 197-198
178. Keay S.D., Barlow R., Eley A., Masson G.M., Anthony F.W., and Jenkins J.M. The relation between immunoglobulin G antibodies to Chlamydia trachomatis and poor ovarian response to gonadotropin stimulation before in vitro fertilization. Fertil Steril 70 (1998) 214-218
179. Keay S.D., Liversedge N.H., and Jenkins J.M. Could ovarian infection impair ovarian response to gonadotrophin stimulation?. Br J Obstet Gynaecol 105 (1998) 252-253
180. Sharara F.I., Scott Jr. R.T., and Seifer D.B. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 179 (1998) 804-812
181. Barnhart K., Dunsmoor-Su R., and Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 77 (2002) 1148-1155
182. Augood C., Duckitt K., and Templeton A.A. Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod 13 (1998) 1532-1539
183. Kato I., Toniolo P., Akhmedkhanov A., Koenig K.L., Shore R., and Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 51 (1998) 1271-1276
184. Kinney A., Kline J., and Levin B. Alcohol, caffeine and smoking in relation to age at menopause. Maturitas 54 (2006) 27-38
185. Gosden R.G., Treloar S.A., Martin N.G., et al. Prevalence of premature ovarian failure in monozygotic and dizygotic twins. Hum Reprod 22 (2007) 610-615
186. Palmer J.S., Zhao Z.Z., Hoekstra C., et al. Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab 91 (2006) 4713-4716
187. Di Pasquale E., Rossetti R., Marozzi A., et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 91 (2006) 1976-1979
188. Laissue P., Christin-Maitre S., Touraine P., et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 154 (2006) 739-744